title: Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.
authors.affiliation: Institute of Pharmacy, University of Tromsø, 9037, Tromso, Norway. ingeborg@farmasi.uit.no
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Hartz
authors.forename: Anne Elise
authors.initials: AE
authors.lastname: Eggen
authors.forename: Sameline
authors.initials: S
authors.lastname: Grimsgaard
authors.forename: Frode
authors.initials: F
authors.lastname: Skjold
authors.forename: Inger
authors.initials: I
authors.lastname: Njølstad
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D004363:Drug Utilization; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012737:Sex Factors; D011795:Surveys and Questionnaires
chemical_list: D000960:Hypolipidemic Agents; D002784:Cholesterol